APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Angiotensin II Type 1 Receptor (AT1R) Antagonists

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173963690326 December 2025184 pages

Choose your research edition.

Industry ResearchAngiotensin II Type 1 Receptor (AT1R) Antagonists Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Angiotensin II Type 1 Receptor (AT1R) Antagonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Angiotensin II Type 1 Receptor (AT1R) Antagonists market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Angiotensin II Type 1 Receptor (AT1R) Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Angiotensin II Type 1 Receptor (AT1R) Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Angiotensin II Type 1 Receptor (AT1R) Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Angiotensin II Type 1 Receptor (AT1R) Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Angiotensin II Type 1 Receptor (AT1R) Antagonists include Takeda Pharmaceutical Co., Ltd., Shenzhen Salubris Pharmaceuticals Co., Ltd., Sanofi SA, Novartis, Merck, AbbVie, Inc., Cosette Pharmaceuticals, Inc. and Aurobindo Pharma Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Angiotensin II Type 1 Receptor (AT1R) Antagonists market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Angiotensin II Type 1 Receptor (AT1R) Antagonists and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Angiotensin II Type 1 Receptor (AT1R) Antagonists sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Angiotensin II Type 1 Receptor (AT1R) Antagonists market size, projected growth trends, production technologies, key applications, and end-use industries.

Angiotensin II Type 1 Receptor (AT1R) Antagonists Segment by Company

Takeda Pharmaceutical Co., Ltd.

Shenzhen Salubris Pharmaceuticals Co., Ltd.

Sanofi SA

Novartis

Merck

AbbVie, Inc.

Cosette Pharmaceuticals, Inc.

Aurobindo Pharma Ltd.

Angiotensin II Type 1 Receptor (AT1R) Antagonists Segment by Type

5mg

10mg

20mg

50mg

80mg

100mg

150mg

400mg

Angiotensin II Type 1 Receptor (AT1R) Antagonists Segment by Application

Hospital

Clinic

Others

Angiotensin II Type 1 Receptor (AT1R) Antagonists Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Angiotensin II Type 1 Receptor (AT1R) Antagonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Angiotensin II Type 1 Receptor (AT1R) Antagonists and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Angiotensin II Type 1 Receptor (AT1R) Antagonists.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Angiotensin II Type 1 Receptor (AT1R) Antagonists market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Angiotensin II Type 1 Receptor (AT1R) Antagonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Angiotensin II Type 1 Receptor (AT1R) Antagonists in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Angiotensin II Type 1 Receptor (AT1R) Antagonists in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Trends Table 2. Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Drivers Table 3. Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Opportunities and Challenges Table 4. Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Restraints Table 5. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Manufacturers Table 9. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Manufacturers, Product Type & Application Table 13. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 5mg Table 17. Major Manufacturers of 10mg Table 18. Major Manufacturers of 20mg Table 19. Major Manufacturers of 50mg Table 20. Major Manufacturers of 80mg Table 21. Major Manufacturers of 100mg Table 22. Major Manufacturers of 150mg Table 23. Major Manufacturers of 400mg Table 24. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2021-2026) & (K Units) Table 26. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2027-2032) & (K Units) Table 27. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Type (2021-2026) Table 28. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Type (2027-2032) Table 29. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 30. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2021-2026) & (K Units) Table 31. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2027-2032) & (K Units) Table 32. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Type (2021-2026) Table 33. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Type (2027-2032) Table 34. Major Manufacturers of Hospital Table 35. Major Manufacturers of Clinic Table 36. Major Manufacturers of Others Table 37. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2021-2026) & (K Units) Table 39. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2027-2032) & (K Units) Table 40. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Application (2021-2026) Table 41. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Application (2027-2032) Table 42. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 43. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2021-2026) & (K Units) Table 44. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2027-2032) & (K Units) Table 45. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Application (2021-2026) Table 46. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Application (2027-2032) Table 47. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 48. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Region (2021-2026) & (K Units) Table 49. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Region (2021-2026) Table 50. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Forecasted by Region (2027-2032) & (K Units) Table 51. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Forecasted Market Share by Region (2027-2032) Table 52. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021-2026) & (K Units) Table 54. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2027-2032) & (K Units) Table 55. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021-2026) & (K Units) Table 57. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2027-2032) & (K Units) Table 58. Asia Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. Asia Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021-2026) & (K Units) Table 60. Asia Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2027-2032) & (K Units) Table 61. South America, Middle East and Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 62. South America, Middle East and Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021-2026) & (K Units) Table 63. South America, Middle East and Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2027-2032) & (K Units) Table 64. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Region (2021-2026) & (US$ Million) Table 66. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Region (2027-2032) & (US$ Million) Table 67. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Region (2021-2026) Table 68. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Region (2027-2032) Table 69. Takeda Pharmaceutical Co., Ltd. Company Information Table 70. Takeda Pharmaceutical Co., Ltd. Business Overview Table 71. Takeda Pharmaceutical Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Takeda Pharmaceutical Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio Table 73. Takeda Pharmaceutical Co., Ltd. Recent Development Table 74. Shenzhen Salubris Pharmaceuticals Co., Ltd. Company Information Table 75. Shenzhen Salubris Pharmaceuticals Co., Ltd. Business Overview Table 76. Shenzhen Salubris Pharmaceuticals Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Shenzhen Salubris Pharmaceuticals Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio Table 78. Shenzhen Salubris Pharmaceuticals Co., Ltd. Recent Development Table 79. Sanofi SA Company Information Table 80. Sanofi SA Business Overview Table 81. Sanofi SA Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Sanofi SA Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio Table 83. Sanofi SA Recent Development Table 84. Novartis Company Information Table 85. Novartis Business Overview Table 86. Novartis Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Novartis Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio Table 88. Novartis Recent Development Table 89. Merck Company Information Table 90. Merck Business Overview Table 91. Merck Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Merck Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio Table 93. Merck Recent Development Table 94. AbbVie, Inc. Company Information Table 95. AbbVie, Inc. Business Overview Table 96. AbbVie, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. AbbVie, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio Table 98. AbbVie, Inc. Recent Development Table 99. Cosette Pharmaceuticals, Inc. Company Information Table 100. Cosette Pharmaceuticals, Inc. Business Overview Table 101. Cosette Pharmaceuticals, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Cosette Pharmaceuticals, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio Table 103. Cosette Pharmaceuticals, Inc. Recent Development Table 104. Aurobindo Pharma Ltd. Company Information Table 105. Aurobindo Pharma Ltd. Business Overview Table 106. Aurobindo Pharma Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Aurobindo Pharma Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio Table 108. Aurobindo Pharma Ltd. Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Angiotensin II Type 1 Receptor (AT1R) Antagonists Distributors List Table 112. Angiotensin II Type 1 Receptor (AT1R) Antagonists Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Image Figure 2. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size (2021-2032) & (US$ Million) Figure 4. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (2021-2032) & (K Units) Figure 5. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Angiotensin II Type 1 Receptor (AT1R) Antagonists Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 5mg Image Figure 9. 10mg Image Figure 10. 20mg Image Figure 11. 50mg Image Figure 12. 80mg Image Figure 13. 100mg Image Figure 14. 150mg Image Figure 15. 400mg Image Figure 16. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share 2021 VS 2025 VS 2032 Figure 18. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Type (2021-2032) Figure 19. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Type (2021-2032) Figure 22. Hospital Image Figure 23. Clinic Image Figure 24. Others Image Figure 25. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Application (2021-2032) Figure 28. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 29. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Application (2021-2032) Figure 31. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 32. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Country (2021-2032) Figure 33. U.S. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Canada Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Mexico Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Country (2021-2032) Figure 38. Germany Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 39. France Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 40. U.K. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Italy Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Netherlands Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Asia Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Country (2021-2032) Figure 45. China Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Japan Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Korea Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Southeast Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 49. India Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Australia Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South America, Middle East and Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Country (2021-2032) Figure 53. Brazil Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 54. South Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Saudi Arabia Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Turkey Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Argentina Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 58. UAE Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Egypt Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Chile Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 61. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Figure 64. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Figure 66. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. Angiotensin II Type 1 Receptor (AT1R) Antagonists Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • 5mg
  • 10mg
  • 20mg
  • 50mg
  • 80mg
  • 100mg
  • 150mg
  • 400mg
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Takeda Pharmaceutical Co., Ltd.
  • Shenzhen Salubris Pharmaceuticals Co., Ltd.
  • Sanofi SA
  • Novartis
  • Merck
  • AbbVie, Inc.
  • Cosette Pharmaceuticals, Inc.
  • Aurobindo Pharma Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Dynamics
  1. 2.1 Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Trends
  2. 2.2 Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Drivers
  3. 2.3 Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Opportunities and Challenges
  4. 2.4 Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Restraints
3 Angiotensin II Type 1 Receptor (AT1R) Antagonists Market by Manufacturers
  1. 3.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Manufacturers (2021-2026)
  3. 3.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Manufacturers, Product Type & Application
  7. 3.7 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Angiotensin II Type 1 Receptor (AT1R) Antagonists Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Angiotensin II Type 1 Receptor (AT1R) Antagonists Tier 1, Tier 2, and Tier 3
4 Angiotensin II Type 1 Receptor (AT1R) Antagonists Market by Type
  1. 4.1 Angiotensin II Type 1 Receptor (AT1R) Antagonists Type Introduction
  2. 4.1.1 5mg
  3. 4.1.2 10mg
  4. 4.1.3 20mg
  5. 4.1.4 50mg
  6. 4.1.5 80mg
  7. 4.1.6 100mg
  8. 4.1.7 150mg
  9. 4.1.8 400mg
  10. 4.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type
  11. 4.2.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2021 VS 2025 VS 2032)
  12. 4.2.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2021-2032)
  13. 4.2.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Type (2021-2032)
  14. 4.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type
  15. 4.3.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2021 VS 2025 VS 2032)
  16. 4.3.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2021-2032)
  17. 4.3.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Type (2021-2032)
5 Angiotensin II Type 1 Receptor (AT1R) Antagonists Market by Application
  1. 5.1 Angiotensin II Type 1 Receptor (AT1R) Antagonists Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application
  6. 5.2.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2021-2032)
  8. 5.2.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Application (2021-2032)
  9. 5.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application
  10. 5.3.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2021-2032)
  12. 5.3.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Application (2021-2032)
6 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Region
  1. 6.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Region (2021-2032)
  3. 6.2.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Region (2021-2026)
  4. 6.2.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Region
  1. 7.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Region
  2. 7.1.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Region (2021-2026)
  4. 7.1.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Region (2027-2032)
  5. 7.1.4 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032)
  8. 7.2.2 North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032)
  11. 7.3.2 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda Pharmaceutical Co., Ltd.
  2. 8.1.1 Takeda Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Takeda Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Takeda Pharmaceutical Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Pharmaceutical Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio
  6. 8.1.5 Takeda Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Shenzhen Salubris Pharmaceuticals Co., Ltd.
  8. 8.2.1 Shenzhen Salubris Pharmaceuticals Co., Ltd. Company Information
  9. 8.2.2 Shenzhen Salubris Pharmaceuticals Co., Ltd. Business Overview
  10. 8.2.3 Shenzhen Salubris Pharmaceuticals Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shenzhen Salubris Pharmaceuticals Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio
  12. 8.2.5 Shenzhen Salubris Pharmaceuticals Co., Ltd. Recent Developments
  13. 8.3 Sanofi SA
  14. 8.3.1 Sanofi SA Company Information
  15. 8.3.2 Sanofi SA Business Overview
  16. 8.3.3 Sanofi SA Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi SA Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio
  18. 8.3.5 Sanofi SA Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio
  30. 8.5.5 Merck Recent Developments
  31. 8.6 AbbVie, Inc.
  32. 8.6.1 AbbVie, Inc. Company Information
  33. 8.6.2 AbbVie, Inc. Business Overview
  34. 8.6.3 AbbVie, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 AbbVie, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio
  36. 8.6.5 AbbVie, Inc. Recent Developments
  37. 8.7 Cosette Pharmaceuticals, Inc.
  38. 8.7.1 Cosette Pharmaceuticals, Inc. Company Information
  39. 8.7.2 Cosette Pharmaceuticals, Inc. Business Overview
  40. 8.7.3 Cosette Pharmaceuticals, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Cosette Pharmaceuticals, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio
  42. 8.7.5 Cosette Pharmaceuticals, Inc. Recent Developments
  43. 8.8 Aurobindo Pharma Ltd.
  44. 8.8.1 Aurobindo Pharma Ltd. Company Information
  45. 8.8.2 Aurobindo Pharma Ltd. Business Overview
  46. 8.8.3 Aurobindo Pharma Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Aurobindo Pharma Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio
  48. 8.8.5 Aurobindo Pharma Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Angiotensin II Type 1 Receptor (AT1R) Antagonists Value Chain Analysis
  2. 9.1.1 Angiotensin II Type 1 Receptor (AT1R) Antagonists Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Mode & Process
  6. 9.2 Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Angiotensin II Type 1 Receptor (AT1R) Antagonists Distributors
  9. 9.2.3 Angiotensin II Type 1 Receptor (AT1R) Antagonists Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst